Syncona

Syncona

London, Englandsynconaltd.com

Overview

Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of high unmet need. Syncona is a leading life science investor focused on creating, building and scaling global leaders in life science. Syncona's purpose is to invest to extend and enhance human life.

Year Founded

2012

Portfolio Companies

16

Investments

CompanyDateStageLead
Beacon TherapeuticsJan 2026Series CCo-investor
Apini TherapeuticsJun 2025SeedCo-investor
Apini TherapeuticsNov 2024AcceleratorLead
Resolution TherapeuticsOct 2024Series BLead
Beacon TherapeuticsJul 2024Series BCo-investor

Key People

Roel Bulthuis

Managing Partner

Ben Woolven

Business Strategy And Operations Partner

Elisa Petris

Partner

Hitesh Thakrar

Partner

John Tsai

Executive Partner

Gonzalo Garcia

Principal

Alex Hamilton

Investor

Michael Kyriakides

Life Sciences Company Builder And Investor

Usman Sherani

Investor Relations Corporate Communications And Sustainability Associate

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersLondon, England
Year Founded2012

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.